UNSPSC 51161731: Ambroxol/salbutamol
Commodity
Code facts
- Part of
-
-
51000000
-
51160000
- 51161700
-
51160000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51161731
| NIGP code |
|---|
| 26904 Antihistamine Drugs |
Definition
This classification denotes a combination drug composed of two constituents: a mucolytic and bronchodilator and beta-adrenergic agonist, as more fully appears.
The first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula C13H18BR2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 200168S0CL, chemically known as 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [EU/ESIS 242-500-3]; ambroxol comes in forms acefyllinate [0HM1E174TN], base, and hydrochloride [CC995ZMV90].
Read the full definition
European Medicines Agency schedules AMBROXOL in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05397MIG (base), SUB12842MIG (acefyllinate), and SUB00427MIG (hydrochloride). The term AMBROXOL is an International Non-Proprietary Name or INN. World Health Organization schedules ambroxol in its Anatomical Therapeutic Chemical (ATC) Classification (R05CB06) and in its WHO Drug Dictionary. AMBROXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Most nations schedule ambroxol under HS 29221980 and SITC 51461. US Census, for industry purposes, classifies ambroxol under NAICS 325199. The second component of this combination drug, salbutamol (51391703), is a bronchodilator and beta-adrenergic agonist with the molecular formula C13H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QF8SVZ843E, chemically known as 1,3-benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy- but generally known as albuterol, which bears US NIH Compound Identifier 2083.
Albuterol comes in many forms, including adipate diethanolate, di-methylboronate, n-butylboronate, and sulfate. European Medicines Agency schedules Albuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10422MIG. The term SALBUTAMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules albuterol in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule albuterol under HS 29225090 and SITC 51467.
As of Q4 2014, ALBUTEROL remains the US FDA Preferred Term for this commodity. Albuterol bears US NLM identifiers UMLS ID C0001927 and NCI Concept Code C215.
About UNSPSC 51161731
UNSPSC 51161731 Ambroxol/salbutamol is a Commodity code that state and local governments are using to procure pharmaceutical products and pharmacy services for community health and employee benefit programs. The recent opportunities under this code show state and local agencies purchasing emergency medications such as naloxone, comprehensive pharmacy services including medication dispensing and formulary management, and related clinical support. Issuing bodies include county health departments and county employee benefits administrators, typically procuring through IFB and RFQ mechanisms to serve defined patient or employee populations. The work spans emergency pharmaceutical response (naloxone acquisition for opioid overdose reversal) and ongoing clinical pharmacy operations at county health centers.
Recent activity appears concentrated in the Southeast. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building, with a response deadline of July 26, 2023. Hall County, Georgia issued RFQ/P #47-010 in May 2026 to procure on-site pharmacy services at its Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible individuals across multiple insurance plans; the solicitation required 80 scored technical evaluation questions and a separate sealed cost proposal using an 80/20 scoring structure, with responses due June 4, 2026. Both procurements required E-Verify compliance and comprehensive insurance documentation, and neither specified set-aside designations for disadvantaged enterprises.
Quick answers
What is UNSPSC 51161731?
UNSPSC 51161731 is Ambroxol/
Which NIGP codes match UNSPSC 51161731?
UNSPSC 51161731 maps to 1 NIGP code, 26904 Antihistamine Drugs.
On GovTribe
See everything under UNSPSC 51161731
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code